Top Gainers for 5-19-22: $INDP $NURO

$INDP - Indaptus Therapeutics Announces FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Decoy20 in Solid Tumors: https://finance.yahoo.com/news/indaptus-therapeutics-announces-fda-clearance-110000411.html

$NURO - NeuroMetrix Reports that Quell® Wearable Neuromodulation Device has Received FDA De Novo Authorization as First Non-Pharmacological Treatment for Fibromyalgia: https://finance.yahoo.com/news/neurometrix-reports-quell-wearable-neuromodulation-130000540.html